Carta científico-clínica
Sevoflurano, ¿una alternativa en el tratamiento de las úlceras vasculares?
Sevoflurane: A Valid Alternative for the Treatment of Vascular Ulcers?
Leído
19960
Vecesse ha leído el artículo
5086
Total PDF
14874
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 297 | 22 | 319 |
| 2025 5 | 305 | 42 | 347 |
| 2025 4 | 297 | 34 | 331 |
| 2025 3 | 334 | 25 | 359 |
| 2025 2 | 278 | 41 | 319 |
| 2025 1 | 262 | 40 | 302 |
| 2024 12 | 361 | 22 | 383 |
| 2024 11 | 267 | 63 | 330 |
| 2024 10 | 226 | 43 | 269 |
| 2024 9 | 188 | 28 | 216 |
| 2024 8 | 254 | 61 | 315 |
| 2024 7 | 307 | 29 | 336 |
| 2024 6 | 317 | 42 | 359 |
| 2024 5 | 336 | 43 | 379 |
| 2024 4 | 280 | 29 | 309 |
| 2024 3 | 337 | 28 | 365 |
| 2024 2 | 371 | 37 | 408 |
| 2024 1 | 427 | 39 | 466 |
| 2023 12 | 385 | 19 | 404 |
| 2023 11 | 381 | 37 | 418 |
| 2023 10 | 363 | 53 | 416 |
| 2023 9 | 324 | 31 | 355 |
| 2023 8 | 275 | 29 | 304 |
| 2023 7 | 206 | 47 | 253 |
| 2023 6 | 209 | 72 | 281 |
| 2023 5 | 294 | 32 | 326 |
| 2023 4 | 160 | 36 | 196 |
| 2023 3 | 147 | 42 | 189 |
| 2023 2 | 128 | 31 | 159 |
| 2022 1 | 120 | 48 | 168 |
| 2022 12 | 100 | 46 | 146 |
| 2022 11 | 151 | 43 | 194 |
| 2022 10 | 102 | 59 | 161 |
| 2022 9 | 149 | 89 | 238 |
| 2022 8 | 151 | 61 | 212 |
| 2022 7 | 169 | 58 | 227 |
| 2022 6 | 87 | 43 | 130 |
| 2022 5 | 144 | 39 | 183 |
| 2022 4 | 150 | 45 | 195 |
| 2022 3 | 142 | 70 | 212 |
| 2022 2 | 130 | 41 | 171 |
| 2021 1 | 154 | 40 | 194 |
| 2021 12 | 93 | 50 | 143 |
| 2021 11 | 90 | 57 | 147 |
| 2021 10 | 87 | 63 | 150 |
| 2021 9 | 111 | 58 | 169 |
| 2021 8 | 92 | 44 | 136 |
| 2021 7 | 97 | 27 | 124 |
| 2021 6 | 80 | 34 | 114 |
| 2021 5 | 94 | 50 | 144 |
| 2021 4 | 184 | 120 | 304 |
| 2021 3 | 168 | 45 | 213 |
| 2021 2 | 102 | 45 | 147 |
| 2020 1 | 83 | 49 | 132 |
| 2020 12 | 97 | 39 | 136 |
| 2020 11 | 54 | 10 | 64 |
| 2020 10 | 66 | 39 | 105 |
| 2020 9 | 74 | 27 | 101 |
| 2020 8 | 51 | 16 | 67 |
| 2020 7 | 50 | 21 | 71 |
| 2020 6 | 49 | 21 | 70 |
| 2020 5 | 64 | 45 | 109 |
| 2020 4 | 66 | 38 | 104 |
| 2020 3 | 40 | 28 | 68 |
| 2020 2 | 7 | 6 | 13 |
| 2020 1 | 0 | 2 | 2 |
| 2019 12 | 4 | 16 | 20 |
| 2019 11 | 0 | 18 | 18 |
| 2019 10 | 17 | 15 | 32 |
| 2019 9 | 6 | 18 | 24 |
| 2019 8 | 0 | 7 | 7 |
| 2019 7 | 1 | 21 | 22 |
| 2019 6 | 0 | 19 | 19 |
| 2019 5 | 3 | 43 | 46 |
| 2019 4 | 0 | 69 | 69 |
| 2019 3 | 0 | 43 | 43 |
| 2019 2 | 2 | 37 | 39 |
| 2019 1 | 1 | 23 | 24 |
| 2018 12 | 10 | 31 | 41 |
| 2018 11 | 3 | 39 | 42 |
| 2018 10 | 3 | 11 | 14 |
| 2018 9 | 3 | 14 | 17 |
| 2018 8 | 0 | 66 | 66 |
| 2018 7 | 0 | 38 | 38 |
| 2018 6 | 3 | 56 | 59 |
| 2018 5 | 0 | 63 | 63 |
| 2018 4 | 0 | 62 | 62 |
| 2018 3 | 11 | 45 | 56 |
| 2018 2 | 166 | 72 | 238 |
| 2018 1 | 122 | 43 | 165 |
| 2017 12 | 106 | 38 | 144 |
| 2017 11 | 77 | 71 | 148 |
| 2017 10 | 123 | 53 | 176 |
| 2017 9 | 79 | 63 | 142 |
| 2017 8 | 102 | 63 | 165 |
| 2017 7 | 109 | 49 | 158 |
| 2017 6 | 76 | 80 | 156 |
| 2017 5 | 93 | 47 | 140 |
| 2017 4 | 97 | 80 | 177 |
| 2017 3 | 89 | 78 | 167 |
| 2017 2 | 113 | 94 | 207 |
| 2016 1 | 56 | 54 | 110 |
| 2016 12 | 90 | 13 | 103 |
| 2016 11 | 109 | 44 | 153 |
| 2016 10 | 121 | 72 | 193 |
| 2016 9 | 152 | 80 | 232 |
| 2016 8 | 83 | 62 | 145 |
| 2016 7 | 69 | 35 | 104 |
| 2016 6 | 22 | 28 | 50 |
| 2016 5 | 7 | 23 | 30 |
| 2016 4 | 9 | 5 | 14 |
| 2016 3 | 8 | 32 | 40 |
| 2016 2 | 10 | 1 | 11 |
| 2015 1 | 11 | 1 | 12 |
| 2015 12 | 7 | 20 | 27 |
| 2015 11 | 7 | 1 | 8 |
| 2015 10 | 6 | 25 | 31 |
| 2015 9 | 2 | 21 | 23 |
| 2015 8 | 3 | 12 | 15 |
| 2015 7 | 58 | 20 | 78 |
| 2015 6 | 83 | 19 | 102 |
| 2015 5 | 78 | 30 | 108 |
| 2015 4 | 41 | 21 | 62 |
| 2015 3 | 54 | 20 | 74 |
| 2015 2 | 44 | 16 | 60 |
| 2015 1 | 48 | 19 | 67 |
| 2014 12 | 28 | 13 | 41 |
| 2014 11 | 29 | 12 | 41 |
| 2014 10 | 47 | 7 | 54 |
| 2014 9 | 21 | 6 | 27 |
| 2014 8 | 28 | 11 | 39 |
| 2014 7 | 30 | 12 | 42 |
| 2014 6 | 39 | 7 | 46 |
| 2014 5 | 40 | 13 | 53 |
| 2014 4 | 29 | 12 | 41 |
| 2014 3 | 22 | 21 | 43 |
Mostrar todo
